[go: up one dir, main page]

AR073871A1 - Intermediario de fulvestran - Google Patents

Intermediario de fulvestran

Info

Publication number
AR073871A1
AR073871A1 ARP090103963A ARP090103963A AR073871A1 AR 073871 A1 AR073871 A1 AR 073871A1 AR P090103963 A ARP090103963 A AR P090103963A AR P090103963 A ARP090103963 A AR P090103963A AR 073871 A1 AR073871 A1 AR 073871A1
Authority
AR
Argentina
Prior art keywords
fulvestran
intermediary
preparation
acetyl
group
Prior art date
Application number
ARP090103963A
Other languages
English (en)
Inventor
Ettema Gerrit Jan Bouke
Reinerus Gerardus Gieling
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of AR073871A1 publication Critical patent/AR073871A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se relaciona con un compuesto de la formula (1) en donde R1 representa H o un grupo acetilo y R2 representa un grupo metilo, acetilo o bencilo; con su preparacion y con su uso en la preparacion de fulvestrant.
ARP090103963A 2008-10-15 2009-10-15 Intermediario de fulvestran AR073871A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10562608P 2008-10-15 2008-10-15

Publications (1)

Publication Number Publication Date
AR073871A1 true AR073871A1 (es) 2010-12-09

Family

ID=41664932

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090103963A AR073871A1 (es) 2008-10-15 2009-10-15 Intermediario de fulvestran

Country Status (5)

Country Link
US (1) US20100105934A1 (es)
EP (1) EP2350111A1 (es)
CN (1) CN102227441A (es)
AR (1) AR073871A1 (es)
WO (1) WO2010043404A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016027000A (ja) * 2012-10-09 2016-02-18 学校法人早稲田大学 ステロイド化合物及びこれを含有する医薬
CA2884806A1 (en) 2012-10-22 2014-05-01 Intas Pharmaceuticals Limited An improved process for the preparation of fulvestrant
WO2015181116A1 (en) 2014-05-26 2015-12-03 Crystal Pharma, S.A.U. Process and intermediades for the preparation of 7-alkylated steroids
CN107286213A (zh) * 2016-03-31 2017-10-24 杭州共泽医药科技有限公司 一种氟维司群中间体的制备方法
TWI793165B (zh) 2017-09-11 2023-02-21 美商阿托薩醫療公司 製造及使用因多昔芬(endoxifen)之方法
US12201591B2 (en) 2019-07-03 2025-01-21 Atossa Therapeutics, Inc. Sustained release compositions of endoxifen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
DE4218743C2 (de) * 1992-06-04 2001-10-25 Schering Ag Verfahren zur Herstellung C(7)-substituierter Estra-1,3,5(10)-triene sowie neue Ausgangsprodukte für dieses Verfahren
TW548277B (en) * 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
GB0123961D0 (en) * 2001-10-05 2001-11-28 Astrazeneca Ab Process and intermediates

Also Published As

Publication number Publication date
WO2010043404A1 (en) 2010-04-22
EP2350111A1 (en) 2011-08-03
US20100105934A1 (en) 2010-04-29
CN102227441A (zh) 2011-10-26

Similar Documents

Publication Publication Date Title
DK2044028T3 (da) Cyanoisoquinolinforbindelser til stabilisering af den hypoxiinducerende faktor (HIF)
NO20071880L (no) Diagnostic Compounds
BRPI0607279A2 (pt) composição compatìvel com fertilizante
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
AR083234A1 (es) Composicion pesticida y su uso
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
NL2002255A1 (nl) Antilichamen tegen myostatine.
CR10847A (es) Compuesto heteromonociclico y uso del mismo
EA201070519A1 (ru) Соединения тропана
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
DK1893587T3 (da) Fremgangsmåde til fremstilling af dihydroquinazoliner
BRPI1014914A2 (pt) Composição contendo trehalulose, sua preparação e uso
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
AR073871A1 (es) Intermediario de fulvestran
BRPI0916480A2 (pt) composto de fórmula geral (i) e uso de pelo menos um composto
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
EP1948254A4 (en) HYDROCOLLOID COMPOSITION
UY30801A1 (es) Compuestos calciliticos
FR2880904B1 (fr) Perfectionnements au mode de construction par elements standardises
ECSP109874A (es) Nuevos compuestos 892
AR063597A1 (es) Nueva sal
BRPI0907797A2 (pt) Novo uso de 3,3'-diindolimetano
RU2007112594A (ru) Производные гиалуроновой кислоты с пониженной биодеградируемостью

Legal Events

Date Code Title Description
FB Suspension of granting procedure